India firm issues clarification after Abhayrab rabies vaccine found substandard

India Immunologicals (IIL) has issued a statement on the Abhayrab Rabies Vaccine that was earlier flagged as substandard by the nation's drug authority. The company said that it had received "queries from healthcare professionals" regarding the vaccine and its batch number KE25012.Detailing the incident, the firm first said that the Central Drugs Standard Control Organisation drew vials from "an unlicensed residential premises" in Mukherjee Nagar, Delhi.Stay up to date with the latest news. Foll...

This story was originally reported by Khaleej Times. As an automated real-time news aggregator, NewsToolBar provides multi-perspective indexing and AI summarization while directing full readership directly to primary publisher sources.